[1]高毅超,王泓午.基于真实世界HIS数据分析冠心病患者的临床特征及用药规律[J].医学信息,2022,35(13):1-6，11.[doi:10.3969/j.issn.1006-1959.2022.13.001]
　GAO Yi-chao,WANG Hong-wu.Analysis of Clinical Characteristics and Medication Rules of Patients with Coronary Heart Disease Based on Real World HIS Data[J].Medical Information,2022,35(13):1-6，11.[doi:10.3969/j.issn.1006-1959.2022.13.001]
点击复制

基于真实世界HIS数据分析冠心病患者的临床特征及用药规律()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
35卷
期数:
2022年13期
页码:
1-6，11
栏目:
医学数据科学
出版日期:
2022-07-01

文章信息/Info

Title:
Analysis of Clinical Characteristics and Medication Rules of Patients with Coronary Heart Disease Based on Real World HIS Data
文章编号:
1006-1959（2022）13-0001-07
作者:
高毅超; 王泓午
（1.天津市南开区中医医院中医科，天津 300193；2.天津中医药大学健康科学与工程学院，天津 301617）
Author(s):
GAO Yi-chao; WANG Hong-wu
(1.Department of Traditional Chinese Medicine,Nankai District Hospital of Traditional Chinese Medicine,Tianjin 300193,China;2.School of Health Science and Engineering,Tianjin University of Traditional Chinese Medicine,Tianjin 301617,China)
关键词:
真实世界研究; 冠心病; 舌象; 脉象
Keywords:
Real world study; Coronary heart disease; Tongue manifestation; Pulse manifestation
分类号:
R259
DOI:
10.3969/j.issn.1006-1959.2022.13.001
文献标志码:
A
摘要:
目的 收集整理HIS中冠心病患者的诊疗信息，探求真实世界研究中经中西医结合诊治的冠心病患者的临床特征及用药规律，为冠心病的诊断、治疗提供更为可靠的依据。方法 选取我院2018-2020年1069例冠心病患者的医疗电子数据信息，采用频数统计患者的性别、年龄、发病节气、证型、合并疾病等情况；采用关联规则分析患者的症状、舌象、脉象、用药，分析其常见症状、体征、联合用药等。结果 1069例患者以女性居多（61.18%），年龄在50~80岁；职业大部分集中在商业工作人员，服务性工作人员及生产工作、运输工作和部分体力劳动者之中；发病节气以寒露、霜降、立冬、小雪、大雪等为多见；症状多为胸闷、憋气、心悸；舌象主要有舌暗红苔白、苔黄、苔白腻、苔薄白、苔黄腻，舌淡红苔白，舌红少苔；脉象主要有沉细、弦滑、细弱；主要证型有心血瘀阻证（36.14%）、心气阴两虚证（30.98%）、心肾阳虚证（16.12%）和痰阻心脉证（14.66%）；常联合应用的三种药物组合是抗心绞痛药+抗凝血药+活血化瘀类药、抗心绞痛药+抗凝血药+营养类药、抗心绞痛药+调血脂药+抗凝血药、抗心绞痛药+调血脂药+活血化瘀类药、抗心绞痛药+调血脂药+营养类药。结论 真实世界研究中，冠心病患者的症状、舌象、脉象可以反映出其临床特征，体现了中医学辨证论治的特点和优势。中西医结合治疗用药具有一定的规律性，并且与相关诊疗指南内容相一致。
Abstract:
Objective To collect and sort out the diagnosis and treatment information of patients with coronary heart disease in HIS, explore the clinical characteristics and medication rules of patients with coronary heart disease treated by integrated traditional Chinese and Western medicine in real world research, and provide more reliable basis for the diagnosis and treatment of coronary heart disease.Methods A total of 1069 cases of medical data information of coronary heart disease patients in our hospital from 2018 to 2020 were studied. Frequency statistics were used to analyze the gender, age, onset solar term, syndrome type and complication; association rules were used to analyze the symptoms, tongue manifestation, pulse manifestation and medication, and the common symptoms, signs and combined medication were obtained.Results Totally 1069 patients were mostly female (61.18%), aged 50-80 years old; the majority of occupations were concentrated in commercial staff, service staff and productive, transport and some physical workers; the onset of febrile was Cold Dew, Frost’s Descent, the Beginning of Winter, Lesser Snow, Greater Snow, etc.; most of the symptoms were chest tightness, suffocation and palpitation; the main tongue manifestation include dark red tongue with white fur, yellow fur, white-greasy fur, white and thin fur, yellow-greasy fur, light red tongue with white fur, red tongue with less fur; the pulse manifestation mainly had deep and thin, wiry and rolling, slender and weak; the main syndrome types were Xinxueyuzu (36.14%), Xinqiyinliangxu (30.98%), Xinshenyangxu (16.12%), and Tanzuxinmai (14.66%); the three drug combinations commonly used in combination were antianginal drugs+anticoagulant+Huoxuehuayu drugs, antianginal drugs+anticoagulant+nutrition drugs, antianginal drugs+lipid-regulating drugs+anticoagulant, antianginal drugs+lipid-regulating drugs+Huoxuehuayu drugs, antianginal drugs+lipid-regulating drugs+nutrition drugs.Conclusion In the real world research, the symptoms, tongue manifestation and pulse manifestation of patients with coronary heart disease can reflect their clinical characteristics, reflecting the characteristics and advantages of TCM syndrome differentiation and treatment. The medication of integrated traditional Chinese and Western medicine has certain regularity, which is consistent with the content of relevant diagnosis and treatment guidelines.

参考文献/References:

[1]曹波.我院20岁及以上居民冠心病发病率变化趋势及类型分析[J].心血管病防治知识(学术版),2017(8):32-34.[2]中华人民共和国卫生部.2012年中国卫生统计年鉴[M].北京:中国协和医科大学出版社,2012:269.[3]胡盛寿,高润霖,刘力生,等.《中国心血管病报告2018》概要[J].中国循环杂志,2019,34(3):209-220.[4]徐艳萍.信息化医院HIS系统与LIS系统的集成分析[J].信息与电脑(理论版),2021,33(3):49-50.[5]孙鑫,谭婧,唐立,等.重新认识真实世界研究[J].中国循证医学杂志,2017,17(2):126-130.[6]Kaplan NM,Sproul LE,Mulcahy WS.Large prospective study of ramipril in patients with hypertension. CARE Investigators[J].Clinical therapeutics,1993,15(5):810-818.[7]黄卓山,罗艳婷,刘金来.真实世界研究的方法与实践[J].循证医学,2014,14(6):364-368.[8]陈吉,孙月,布优祥,等.中医领域真实世界研究现状分析[J].中国循证医学杂志,2018,18(11):1216-1223.[9]谢双峥.古代四时养生思想的历史发展及文献研究[D].南昌:江西中医药大学,2020.[10]陈康.益气活血化痰通络方治疗冠心病稳定型心绞痛疗效观察[J].湖北中医杂志,2020,42(12):34-36.[11]陈胤峰,何庆勇,刘超,等.清热活血方剂干预冠心病心绞痛瘀热互结证临床观察[J].中华中医药杂志,2017,32(9):4288-4291.[12]贾伊昕,李明,陈新宇,等.泻心胶囊治疗瘀热互结型冠心病心绞痛30例临床观察[J].湖南中医杂志,2021,37(3):8-10.[13]谢鹏.国医大师伍炳彩治疗胸痹心痛的学术思想及临床经验探究[D].南昌:江西中医药大学,2019.[14]李崇钗,张明雪.冠心病痰瘀互结证中医证治研究[J].辽宁中医药大学学报,2021,23(1):132-135.[15]田苗,陈智慧,王凤荣.王凤荣应用通脉降浊汤加减治疗心系疾病临床经验总结[J].辽宁中医杂志,2020,47(6):40-42.[16]许宏磊.参芪桂附活血汤辅治冠心病所致心肾阳虚型病窦综合征的效果及对心室重构、动态心电图的影响[J].辽宁中医杂志,2020,47(11):146-149.[17]高健,李军.李军教授治疗冠心病介入术后心绞痛的临床经验总结[J].中国中西医结合杂志,2020,40(3):363-365.[18]李先涛,谢蓉,彭丹虹,等.冠心病(胸痹心痛)痰瘀互结证辨证方式研究[J].辽宁中医杂志,2016,43(10):2073-2076.[19]盛碧,吴金虎,陈永刚,等.基于武汉地区PCI术后患者CYP2C19基因多态性指导氯吡格雷个体化用药的研究[J].国际检验医学杂志,2021,42(4):453-456.[20]张新超,于学忠,陈凤英,等.急性冠脉综合征急诊快速诊治指南(2019)[J].中国急救医学,2019,39(4):301-308.

相似文献/References:

[1]袁 帅,邢晓博,李 晓,等.MTHFR基因多态性与中年男性冠状动脉病变程度的相关研究[J].医学信息,2018,31(03):67.[doi:10.3969/j.issn.1006-1959.2018.03.021]
　YUAN Shuai,XING Xiao-bo,LI Xiao,et al.Association of MTHFR Gene Polymorphism with Coronary Artery Lesions in Middle-aged Men[J].Medical Information,2018,31(13):67.[doi:10.3969/j.issn.1006-1959.2018.03.021]
[2]张挺挺.经股和桡动脉介入治疗冠心病的临床疗效对比[J].医学信息,2018,31(03):114.[doi:10.3969/j.issn.1006-1959.2018.03.038]
　ZHANG Ting-ting.Comparison of Clinical Effects of Interventional Treatment of Coronary Heart Disease by Femoral and Radial Artery[J].Medical Information,2018,31(13):114.[doi:10.3969/j.issn.1006-1959.2018.03.038]
[3]迮艳华.稳心颗粒联合美托洛尔治疗冠心病心律失常的疗效分析[J].医学信息,2018,31(03):139.[doi:10.3969/j.issn.1006-1959.2018.03.049]
　ZE Yan-hua.Therapeutic Effect of Wenxin Granule Combined with Metoprolol on Arrhythmia of Coronary Heart Disease[J].Medical Information,2018,31(13):139.[doi:10.3969/j.issn.1006-1959.2018.03.049]
[4]张 旭.冠心病心绞痛患者进行护理干预的临床效果及 对护理质量影响研究[J].医学信息,2018,31(05):182.[doi:10.3969/j.issn.1006-1959.2018.05.068]
　ZHANG Xu.Clinical Effect of Nursing Intervention in Patients with Angina Pectoris of Coronary Heart Disease and its Influence on Nursing Quality[J].Medical Information,2018,31(13):182.[doi:10.3969/j.issn.1006-1959.2018.05.068]
[5]向明明,赵晓辉.黑龙江省东部地区汉族人群冠心病的危险因素研究[J].医学信息,2018,31(07):122.[doi:10.3969/j.issn.1006-1959.2018.07.041]
　XIANG Ming-ming,ZHAO Xiao-hui.Study on Risk Factors of Coronary Heart Disease in Han Nationality Population in Eastern Heilongjiang Province[J].Medical Information,2018,31(13):122.[doi:10.3969/j.issn.1006-1959.2018.07.041]
[6]王 坤,张永春.血清胆红素水平、单核细胞数、红细胞分布宽度与 冠状动脉病变程度的关系[J].医学信息,2018,31(08):53.[doi:10.3969/j.issn.1006-1959.2018.08.017]
　WANG Kun,ZHANG Yong-chun.Relationship between Serum Bilirubin Level,Monocyte Count,Red Blood Cell Distribution Width and Severity of Coronary Artery Disease[J].Medical Information,2018,31(13):53.[doi:10.3969/j.issn.1006-1959.2018.08.017]
[7]毛红岩.冠状动脉介入治疗冠心病的疗效及 对患者血清炎症因子的影响[J].医学信息,2018,31(10):77.[doi:10.3969/j.issn.1006-1959.2018.10.023]
　MAO Hong-yan.Effect of Coronary Intervention on Coronary Heart Disease and its Influence on Serum Inflammatory Factors[J].Medical Information,2018,31(13):77.[doi:10.3969/j.issn.1006-1959.2018.10.023]
[8]杨锦龙,刘 欢,吕秋菊,等.非糖尿病患者糖化血红蛋白和胰岛素抵抗与 冠状动脉病变程度的相关性研究[J].医学信息,2018,31(10):93.[doi:10.3969/j.issn.1006-1959.2018.10.028]
　YANG Jin-long,LIU Huan,LV Qiu-ju,et al.Correlation between Glycosylated Hemoglobin and Insulin Resistance and Severity of Coronary Artery Disease in Non-diabetic Patients[J].Medical Information,2018,31(13):93.[doi:10.3969/j.issn.1006-1959.2018.10.028]
[9]李 铎,王建华.盐酸曲美他嗪片辅助治疗对冠心病伴心力衰竭患者氧化应激、心肌功能的影响[J].医学信息,2018,31(10):126.[doi:10.3969/j.issn.1006-1959.2018.10.041]
　LI Duo,WANG Jian-hua.Effect of Trimetazidine Hydrochloride Tablets Adjuvant Therapy on Oxidative Stress and Myocardial Function in Patients with Coronary Heart Disease Complicated with Heart Failure[J].Medical Information,2018,31(13):126.[doi:10.3969/j.issn.1006-1959.2018.10.041]
[10]田跃雷.冠心病介入治疗后再狭窄的中西医防治[J].医学信息,2022,35(09):46.[doi:10.3969/j.issn.1006-1959.2022.09.011]
　TIAN Yue-lei.Prevention and Treatment of Restenosis After Percutaneous Coronary Intervention with Chinese and Western Medicine[J].Medical Information,2022,35(13):46.[doi:10.3969/j.issn.1006-1959.2022.09.011]

更新日期/Last Update: 1900-01-01